146
Participants
Start Date
June 1, 2018
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
injection of Lumason (ultrasound contrast agent)
contrast-enhanced ultrasound
ultrasound of the abdomen after injection of ultrasound contrast agent (Lumason)
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Philadelphia
OTHER